The FDA has approved a meditation for the treatment of sickle cell anemia in children aged 2 and older

статья Редакционная

The FDA has approved a meditation for the treatment of sickle cell anemia in children aged 2 and older

Full Text:

PDF (Rus)

Generate QR code

Cited By
Scopus Cited

About the Author

статья Редакционная

Russian Federation

Review

For citations:

The FDA has approved a meditation for the treatment of sickle cell anemia in children aged 2 and older. Pediatric pharmacology. 2026;23(4):520. (In Russ.)

JATS XML

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Pediatric pharmacology

The FDA has approved a meditation for the treatment of sickle cell anemia in children aged 2 and older

Full Text:

About the Author

Review

For citations:

Cookies policy